Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Teriparatide as an adjuvant therapy in the management of advanced-stage medication-related osteonecrosis of the jaw

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology(2025)10.1016/j.oooo.2025.04.001Source: DataRank Database

Teriparatide as an adjuvant therapy in the management of advanced-stage medication-related osteonecrosis of the jaw is a research paper published in Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.49)OA: closedTopics (20)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kevin C. Chung ORCID,Joseph M. Huryn ORCID,Cherry L. Estilo ORCID,Azeez Farooki ORCID,SaeHee K. Yom

Live enrichment

PubMed:40399210 OpenAlex:https://openalex.org/W4409328239

National Cancer Institute

Grant: P30 CA008748

Johnson and Johnson

National Institutes of Health

Janssen Pharmaceutica

FWCI

0.49

Citation Percentile

0.6%

Citation Trend

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S2212440325008508?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2212440325008508?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.oooo.2025.04.001

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40399210

Fields of Study

Bone health and treatmentsBone and Joint DiseasesRadiopharmaceutical Chemistry and Applications

MeSH Terms

AgedFemaleHumansTeriparatideBone Density Conservation AgentsBisphosphonate-Associated Osteonecrosis of the Jaw

Keywords

MedicineOsteonecrosis of the jawTeriparatideAdjuvant therapyStage (stratigraphy)DentistrySurgeryOsteoporosisInternal medicineChemotherapyBisphosphonate

Sustainable Development Goals

SDG 0: Zero hunger

Teriparatide as an adjuvant therapy in the management of advanced-stage medication-related osteonecrosis of the jaw

FAIR Checklist

Authors (6)

Funding (4 grants)

Impact

Open Access

Topics